Rich Pharmaceuticals Inc. | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2013
2015
2016
2017
2018
Cash & Short Term Investments
1.60
15.90
-
40.90
6.20
Total Accounts Receivable
-
-
-
10.00
15.30
Other Current Assets
-
7.60
2.80
-
3.00
Total Current Assets
1.60
23.50
2.80
50.90
24.50
Net Property, Plant & Equipment
-
0.80
3.70
2.10
0.90
Total Investments and Advances
-
-
-
-
12.00
Total Assets
1.60
24.30
6.50
53.00
37.40
ST Debt & Current Portion LT Debt
-
408.20
281.70
1,483.50
1,731.40
Accounts Payable
-
-
-
-
721.10
Other Current Liabilities
31.00
1,251.10
2,116.50
3,895.40
3,943.60
Total Current Liabilities
31.00
1,659.30
2,398.20
5,378.80
6,396.10
Long-Term Debt
-
6.10
-
-
-
Other Liabilities
-
77.80
-
-
-
Total Liabilities
31.00
1,743.20
2,398.20
5,378.80
6,396.10
Common Equity (Total)
29.40
1,724.90
2,397.70
5,331.80
6,364.70
Total Shareholders' Equity
29.40
1,718.90
2,391.70
5,325.80
6,358.70
Total Equity
29.40
1,718.90
2,391.70
5,325.80
6,358.70
Liabilities & Shareholders' Equity
1.60
24.30
6.50
53.00
37.40
Preferred Stock (Carrying Value)
-
6.00
6.00
6.00
6.00
About Rich Pharmaceuticals
View Profile
